XEFTA Xefta Gefitinib 250mg Tablet

Xefta (Gefitinib) 250mg is a prescription drug used to treat patients who had gone through cancer treatments previously and  in whom cancer has spread to other parts of the body.

Manufacturer : Dr Reddy’s Laboratories Ltd.

Strengths available :  250mg

Storage : Store at temperature between 15°C to 25°C.

Dosage :  The recommended dose of Xefta is one 250 mg tablet once a day, taken with or without food. If a dose of Xefta is missed, it should be taken as soon as the patient remembers. If it is less than 12 hours to the next dose, the patient should not take the missed dose. Patients should not take a double dose (two doses at the same time) to make up for a forgotten dose.

Where dosing of whole tablets is not possible, such as patients who are only able to swallow liquids, tablets may be administered as a dispersion in water. The tablet should be dropped into half a glass of drinking water (non-carbonated), without crushing, and the glass stirred until the tablet has dispersed (approximately 15 minutes) and the contents subsequently drunk immediately. The glass should be rinsed with a further half glass of water and the contents drunk. The liquid can also be administered via a nasogastric tube.

Xefta is not recommended for use in children or adolescents as safety and effectiveness in these patient populations has not been studied.

Most common side effects Nausea, Rash, Vomiting, Weakness, Loss of appetite, Dry skin, Diarrhoea, Stomatitis (Inflammation of the mouth).

10 tablets per strip